Last updated:

BPC-157 20mg
BPC-157 is a synthetic pentadecapeptide studied in preclinical gastrointestinal, tissue, vascular and inflammatory-signalling research.
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide that appears primarily in preclinical research literature. Investigators have studied it across gastrointestinal, vascular, tissue-response and inflammatory-signalling models.
The ARVEONIX 20mg listing is a higher-strength catalogue format of the same research peptide offered on the 10mg page. Strength does not change the identity of the molecule or convert preclinical findings into established human outcomes.
Tissue research
BPC-157 20mg · SKU BC20
BPC-157 research context
In stock · $100.00 AUD
BPC-157 research context.
Unlike peptides defined by a single well-characterised receptor target, BPC-157 is discussed across multiple proposed biological pathways. This makes study design and evidence quality particularly important.
Researchers should separate mechanistic hypotheses from replicated findings and distinguish animal or cell-model observations from clinical evidence.
Common research themes.
Study of gastrointestinal tissue and barrier-associated biology.
Investigation of endothelial and vascular signalling.
Preclinical research involving repair-associated cellular processes.
Careful distinction between mechanistic hypotheses and established findings.
Research considerations.
Research findings should always be interpreted within the experimental system in which they were produced. Cell, receptor, tissue, animal and human studies can answer different questions, and results from one model should not automatically be treated as established outcomes in another.
ARVEONIX product pages therefore focus on molecule identity, pathway biology and published research themes rather than presenting experimental observations as guaranteed effects. The information here is not a dosing, treatment or individual-use recommendation.
Use the ARVEONIX calculator for concentration, liquid-volume and U-100 arithmetic using values you enter.
BPC-157 FAQs.
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide used in preclinical research.
How does the 20mg product differ from the 10mg product?
The molecule is the same; the catalogue listing differs in total stated strength.
What areas are studied?
Gastrointestinal, vascular, tissue and inflammatory-signalling models.
Is BPC-157 research predominantly preclinical?
Yes. Much of the commonly discussed literature is preclinical.
What is the SKU?
The 20mg ARVEONIX listing uses SKU BC20.
Is BPC-157 a thymosin peptide?
No. It is distinct from thymosin-beta-derived research peptides such as TB-500.
Does this page provide human-use recommendations?
No.
Related products.
Other ARVEONIX catalogue items you may want to view.
Need concentration or U-100 unit conversions?
Use the ARVEONIX peptide reconstitution calculator to convert vial amount, diluent volume, target dose and syringe units for research planning.